As of 2026-09-23, the Relative Valuation of Akero Therapeutics Inc (AKRO) is (96.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 54.65 USD, the upside of Akero Therapeutics Inc based on Relative Valuation is -276.2%.
The range of the Relative Valuation is (86.87) - (104.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.3x - 29.4x | 26.8x |
| Forward P/E multiples | 24.4x - 30.1x | 27.2x |
| Fair Price | (86.87) - (104.67) | (96.30) |
| Upside | -259.0% - -291.5% | -276.2% |
| Date | P/E |